A phase II, open-label clinical trial evaluating the effect of combined thiamin-biotin supplementation, at moderate (600 mg/day of thiamin and 150 mg/day of biotin) and high (1,200 mg/day of thiamin and 300 mg/day of biotin) dosages, in Huntingtons disease is currently underway (75)
After first-line treatments and diagnostics, including diet change, addition of probiotics, and fecal analysis, were performed, a GI panel determined serum cobalamin, folate, and trypsin-like immunoreactivity
SY: Conceptualization, Data curation, Investigation, Methodology, Writing original draft, Writing review & editing
Order Changes and Cancellation Requests Contact [email protected] immediately to request an order change or cancellation
Theres no single universal definition of what constitutes a microdose of semaglutide or a microdose of tirzepatide
Key Takeaway: Don't chase instant results